WANG Bing-Lei, ZHENG Jia-Hua, YUE Zan, BIAN Xin, SHEN Jian-Hua, LI Yan, WANG Hui-Juan. A Case Report on Polyarteritis Misdiagnosed as Viral Encephalitis[J]. Chinese Journal of Stroke, 2018, 13(02): 180-184.
[1] JENNETTE J C，FALK R J，BACON P A，et al.2012 revised International Chapel Hill ConsensusConference Nomenclature of Vasculitides[J].Arthritis Rheum，2013，65（1）：1-11.[2] ALIBAZ-ONER F，DIRESKENELI H. Update onTakayasu's arteritis[J/OL]. Presse Med，2015，44（6Pt 2）：e259-e265. DOI：10.1016/j.lpm.2015.01.015.[3] GOTHI D，JOSHI J M. A 16-year-old girl withhemoptysis，intermittent loss of Vision，and acarotid bruit[J]. Chest，2008，133（1）：300-304.[4] MWIPATAYI B P，JEFFERY P C，BENINGFIELDS J，et al. Takayasu arteritis：clinical features andmanagement：report of 272 cases[J]. ANZ J Surg，2005，75（3）：110-117.[5] 中华医学会风湿病学分会. 大动脉炎诊断及治疗指南[J]. 中华风湿病学杂志，2011，15（2）：119-120.[6] MAKSIMOWICZ-MCKINNON K，CLARK TM，HOFFMAN G S. Limitations of therapy anda guarded prognosis in an American cohort ofTakayasu arteritis patients[J]. Arthritis Rheum，2007，56（3）：1000-1009.[7] KESER G，DIRESKENELI H，AKSU K.Management of Takayasu arteritis：a systematicreview[J]. Rheumatology（Oxford），2014，53（5）：793-801.[8] PENG Y F，DENG Y B. Serum bilirubinconcentrations in patients with Takayasu arteritis[J].Arch Pathol Lab Med，2017，141（6）：846-850.[9] GUDBRANDSSON B，MOLBERG Ø，PALM Ø.TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; anobservational，population-based time trend study[J].Arthritis Res Ther，2017，19（1）：99.[10] GOEL R，DANDA D，KUMAR S，et al. Rapidcontrol of disease activity by tocilizumab in 10'difficult-to-treat' cases of Takayasu arteritis[J]. Int JRheum Dis，2013，16（6）：754-761.[11] JAIN S，SHARMA N，SINGH S，et al. Takayasuarteritis in children and young indians[J/OL]. Int JCardiol，2000，75（Suppl 1）：S153-S157. https：//doi.org/10.1016/S0167-5273（00）00180-7
